Texas Treasury Safekeeping Trust Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,154
Closed -$535K – 7
2026
Q1
$535K Buy
+6,154
New +$598K 0.09% 5
2025
Q1
– Sell
-4,230
Closed -$237K – 7
2024
Q4
$237K Hold
4,230
– – 0.01% 9
2024
Q3
$222K Hold
4,230
– – 0.01% 9
2024
Q2
$174K Hold
4,230
– – 0.01% 9
2024
Q1
$183K Hold
4,230
– – 0.01% 9
2023
Q4
$194K Hold
4,230
– – 0.02% 9
2023
Q3
$97K Hold
4,230
– – 0.02% 8
2023
Q2
$70K Hold
4,230
– – 0.02% 8
2023
Q1
$75K Buy
+4,230
New +$106K 0.02% 8

Other funds holding RYTM

Texas Treasury Safekeeping Trust Company's RYTM Position: Q2 2026 in Review

Texas Treasury Safekeeping Trust Company sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 6,154 shares — an estimated $535K sold.

Texas Treasury Safekeeping Trust Company first reported a position in RYTM in Q1 2023 and held it in 9 quarters. The position peaked at $535K in Q1 2026. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Texas Treasury Safekeeping Trust Company reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Texas Treasury Safekeeping Trust Company sold 6,154 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $535K.
  • Texas Treasury Safekeeping Trust Company first reported a position in Rhythm Pharmaceuticals in Q1 2023 and held it in 9 quarters.
  • Texas Treasury Safekeeping Trust Company's Rhythm Pharmaceuticals position peaked at $535K in Q1 2026.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Texas Treasury Safekeeping Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.